Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Airborne viable microorganism testing, commonly known as floating bacteria testing, is a fundamental environmental monitoring activity required for pharmaceutical cleanroom qualification and routine microbiological control. This article provides a comprehensive technical overview of the testing principles, sampling procedures, applicable standards such as GB/T 16293 and ISO 14698, acceptance criteria, and practical considerations for pharmaceutical manufacturing workshops.

Technical Overview

Airborne viable microorganism testing, referred to as floating bacteria testing in the pharmaceutical industry, is a quantitative method used to determine the concentration of culturable microorganisms suspended in the air of cleanrooms and controlled environments. In pharmaceutical workshops, airborne bacteria, yeasts, and molds represent a direct contamination risk to products, particularly sterile preparations, biologics, and aseptically processed drugs. The test actively draws a known volume of air through a microbial air sampler, impinges the microorganisms onto nutrient agar surfaces, and reports results as colony forming units per cubic meter (CFU/m³) after incubation.

The test is a core component of cleanroom validation and environmental monitoring programs, performed during as-built, at-rest (static), and operational (dynamic) conditions. It supports compliance with Good Manufacturing Practice (GMP) requirements, demonstrates that heating, ventilation, and air conditioning (HVAC) systems and aseptic processing controls are functioning effectively, and provides data for contamination risk assessments and deviation investigations.

Standards and Acceptance Criteria

Testing is typically performed in accordance with national and international standards and regulatory guidance, including GB/T 16293 (Testing method for airborne microbes in cleanrooms of the pharmaceutical industry), GB 50457 (Code for design of pharmaceutical industry cleanroom), ISO 14698-1 and ISO 14698-2 (biocontamination control of cleanrooms), ISO 14644-1 (air cleanliness classification), and the aseptic manufacturing requirements outlined in EU GMP Annex 1 and equivalent national GMP regulations.

Commonly applied airborne viable limits by cleanroom grade are:

  • Grade A (ISO Class 5) critical zones: less than 1 CFU/m³
  • Grade B (ISO Class 5/6) background for aseptic preparation and filling: not more than 10 CFU/m³
  • Grade C (ISO Class 7/8) preparation areas: not more than 100 CFU/m³
  • Grade D (ISO Class 8) less critical processing areas: not more than 200 CFU/m³

Individual companies may establish internal alert and action limits that are tighter than regulatory limits based on historical trending and process risk.

Testing Samples

Grade A and Grade A/B Air Supply Areas

Air from unidirectional airflow zones such as aseptic filling lines, stopper bowls, open vial handling points, and restricted access barrier system (RABS) or isolator environments, where the strictest limits apply and the highest sampling volumes are required.

Grade B and C Cleanrooms

Air from background rooms surrounding aseptic operations, solution preparation rooms, component washing areas, and sterilization holding rooms, sampled at working height and near critical operations.

Grade D and General Production Areas

Air from packaging areas, storage rooms, and lower classification support areas, where sampling volumes may be reduced in accordance with the applicable limit and standard.

Critical Control Points

Air sampled adjacent to exposed product or product-contact surfaces, such as formulation vessels, filling needles, and lyophilizer loading zones, as defined in the environmental monitoring risk assessment.

Testing Items

The principal test items include:

  • Total airborne aerobic bacterial count, expressed in CFU/m³, using trypticase soy agar (TSA) or soybean casein digest agar
  • Airborne fungal count (yeasts and molds) in CFU/m³, using Sabouraud dextrose agar (SDA) or rose bengal agar where applicable
  • Combined total viable count using dual-incubation schemes covering both bacterial and fungal recovery
  • Optional identification of recovered isolates to genus or species level using microscopy, biochemical assays, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, or DNA sequencing, which supports contamination source investigations

Testing Methods

Impaction Method (Primary Method)

A validated microbial air sampler, typically a sieve-type or slit-type impactor, draws air at a controlled flow rate, commonly 100 L/min or 28.3 L/min, and accelerates it toward the surface of prepared agar plates. Particles carrying viable microorganisms are inertially deposited onto the agar due to their momentum. The sampling time is set according to the required total volume, for example 1,000 L for Grade A and Grade B areas and proportionally reduced volumes for Grade C and Grade D areas, consistent with GB/T 16293 and the sampling plan.

Filtration and Centrifugal Methods (Supplementary)

Membrane filtration samplers capture microorganisms on gelatin or membrane filters, which are then transferred onto agar or dissolved in broth for incubation. Centrifugal samplers use a rotating impeller to deposit airborne particles onto agar strips. These methods are useful for special applications but the impaction method remains the industry standard for routine monitoring.

Sampling Procedure

The general procedure is as follows:

  • Prepare and sterilize culture media, and pre-incubate plates to demonstrate sterility before use
  • Disinfect the sampler surfaces and bring all equipment into the cleanroom, allowing adequate equilibration and purge time after disinfection
  • Position sampling heads at working height, typically 0.8 to 1.5 m above floor level, and at locations defined in the approved sampling plan, avoiding unnecessary disruption of unidirectional airflow during dynamic testing
  • Program the sampler for the specified volume and run the sample, applying a pre-run purge where required
  • Retrieve plates aseptically, incubate without undue delay, and count colonies after the prescribed incubation period
  • Calculate the airborne concentration: CFU/m³ = number of colonies counted divided by the volume of air sampled in cubic meters
  • Record all metadata, including location, state of the room, temperature and humidity, sampler identity, and volume sampled

Incubation Conditions

For bacterial enumeration, TSA plates are typically incubated at 30 to 35 °C for at least 48 hours (up to 72 hours). For fungal enumeration, SDA plates are incubated at 20 to 25 °C for at least 5 days. Dual-temperature incubation schemes, for example 30 to 35 °C followed by 20 to 25 °C, are commonly applied in aseptic processing monitoring in accordance with EU GMP Annex 1 expectations. All incubation conditions and durations must be validated for the recovery of representative environmental isolates.

Result Evaluation

Results are compared against regulatory and internal alert and action limits. Any excursion requires documented investigation, including review of personnel practices, cleaning and disinfection records, HVAC performance, filter integrity, and identification of recovered organisms to determine the probable contamination source. Corrective and preventive actions must be defined and their effectiveness verified through follow-up sampling.

Applications

  • Cleanroom qualification and requalification in as-built, at-rest, and operational states for new pharmaceutical facilities
  • Routine environmental monitoring programs for sterile and non-sterile drug manufacturing workshops
  • Support for aseptic process simulations (media fills) and validation of sterilization and barrier systems such as isolators and RABS
  • Assessment of HVAC system performance, HEPA filter integrity investigations, and airflow pattern studies
  • Contamination excursion investigations and evaluation of corrective actions following adverse trends
  • GMP inspections, licensing submissions, and audits by regulatory authorities or accredited third-party laboratories

FAQ

What is the difference between floating bacteria testing and settle plate testing?

Floating bacteria testing actively aspirates a defined volume of air and provides a quantitative concentration in CFU/m³, whereas settle plate testing is a passive method that measures microorganisms depositing onto an exposed agar plate over time. Active air sampling is more sensitive and quantitative, and the two methods are used together as complementary tools in environmental monitoring programs.

How many sampling points are required in a pharmaceutical workshop?

The number and location of sampling points are determined by the room area, cleanliness grade, and a documented risk assessment, following the principles of GB/T 16293 and ISO 14698-1. Points are placed at working height and prioritized at locations where product or product-contact surfaces are exposed, rather than being distributed solely on a uniform grid.

Should testing be performed in the static or dynamic state?

Both states are evaluated during qualification: at-rest testing verifies the performance of the facility and HVAC system, while operational testing, performed during actual production with personnel and equipment active, reflects the true contamination risk and is the basis for routine monitoring limits.

How often should airborne viable testing be conducted?

Frequency depends on the criticality of the area. Grade A zones and surrounding Grade B areas are typically monitored during every production shift, while Grade C and Grade D areas are monitored on a defined periodic schedule, such as weekly or monthly, based on risk assessment and regulatory expectations.

What measures ensure the accuracy and reliability of results?

Key controls include validation and regular calibration of air samplers, media growth promotion testing, sterility controls, pre- and post-test disinfection of equipment, limits on sampling duration to avoid media desiccation, controlled incubation conditions, and comprehensive documentation of all conditions, volumes, and locations associated with each sample.